摘要
Second generation bioethanol, making use of the polysaccharides included in the lignocellulosic biomass, represents a promising alternative approach to overcome the limitations revealed by first generation bioethanol. The main issue hindering the effective industrial scale utilization of biomass is the lack of low-cost technology. In fact, lignocellulose hydrolysis requires expensive pre-treatments and large dosages of commercial enzymes. Moreover, feedstock pre-treatment results in the formation of inhibitors, mainly weak acids (acetic and formic), furans (furfural and 5-hydroxymethyl-2-furaldehyde) and phenolics, which affect the fermentation phase. Consolidated BioProcessing (CBP) of lignocellulosic biomass is gaining increasing attention as a potential strategy to reduce production costs both by integrating different production steps and by lowering the need for supplying of commercial cellulases. As no naturally occurring fermenting microorganism suitable for CBP has been described yet, genetic engineering of highly fermentative microorganisms, particularly yeast, will be required. To further improve the economic feasibility of the process in industrial scenarios, the search of robust yeast with high inhibitors tolerance as platform for genetic engineering would be desired. In this study, a collection of wild type Saccharomyces cerevisiae yeast, previously selected for their robustness and high ethanol yield, was characterized for inhibitors tolerance on synthetic mixtures of the inhibitors typical of lignocellulosic pre-hydrolysates and on real pre-hydrolysates, rich in these toxic compounds. The best performing strain was chosen as a robust candidate for the expression of three fungal β-glucosidases by δ-integration, together with the benchmark strain Ethanol Red®, currently utilized in industrial bioethanol production. Similarly, two wild-type yeast that were previously successfully used as parental to develop CBP strains, were used for the same purpose. Among the cellulases required for cellulose degradation, β-glucosidase was selected as it plays a key role in the process, representing the rate limiting enzyme. A large amount of recombinant clones, secreting β-glucosidases from the fungal species Saccharomycopsis fibuligera and Phanerochaete chrysosporium, were obtained. The engineered clones were firstly screened for high enzyme activity in a quantitative assay, using esculin as substrate. The β-glucosidase activity of the best performing strains was then quantified on pNPG. One recombinant able to produce high amounts of β-glucosidase demonstrated to be mitotically-stable and capable of sustaining the growth in presence of cellobiose as sole carbon source. The enzymatic activity of the recombinant was characterized in vitro in terms of enzyme localization, optimal pH and temperature, and stability. The fermentative abilities were assessed in defined medium containing cellobiose. The obtained recombinant showed comparable performances to the parental strain on glucose, indicating that β-glucosidase secretion does not cause any severe metabolic burden to the host. Further, the engineered strain could display high ethanol yield when fermenting cellobiose, comparable to those of a laboratory yeast strain expressing the same β-glucosidase via multicopy episomal plasmid, despite the remarkable disadvantage of lower gene copy number guaranteed by gene integration. This study reports the successful construction of S. cerevisiae strains capable of tolerating high inhibitors concentrations and expressing fungal β-glucosidases. To our knowledge, this work represents the first attempt to produce a CBP microorganism for lignocellulosic bioethanol via integration of β-glucosidases into tolerant yeast selected for thermotolerance and resistance to the inhibitors typically present in lignocellulosic pre-hydrolysates. The fermentation performances of the engineered strain will next be studied on sugarcane bagasse hydrolysate, with the aim to confirm the inhibitors tolerance traits.